Targeted screening for Coeliac Disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information

Screening patients with IBS-D or IBS-mix for CD is almost certainly cost-effective. The screening program would improve the quality of life of those patients with IBS symptoms who actually have CD at a relatively low cost. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2013

MoreLess

Year of publication:	2013
Authors:	Mohseninejad, Leyla ; Feenstra, Talitha ; Horst, Henriëtte ; Woutersen-Koch, Hèlen ; Buskens, Erik
Published in:	The European Journal of Health Economics. - Springer. - Vol. 14.2013, 6, p. 947-957
Publisher:	Springer
Subject:	Irritable bowel syndrome \| Coeliac Disease \| Cost-effectiveness analysis \| Value of information analysis \| Screening

More details

Extent:	text/html
Type of publication:	Article
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10010993929